Effects of transcutaneous electrical nerve stimulation (TENS) on memory in elderly with mild cognitive impairment

Luijpen, M.W.; Swaab, Dick F.; Sergeant, Joseph A.; Dijk, Koene R. A. Van; Scherder, E.J.A.

doi:10.1016/j.bbr.2004.09.017

Cited by 8 publications

(6 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the analgesic effect of TENS was thoroughly investigated, there are few works that dealt with its nonantalgic effects. A positive effect has been observed on sickness [ 114 ], on fatigue associated with FM [ 115 ], on distress [ 116 ], on upper [ 117 ] and lower limbs motility [ 116 ], on heart rate variability (HRV) [ 118 ], on pupil dynamics [ 50 ], on peripheral blood flow and cutaneous temperature [ 119 ], on memory and affective behavior [ 120 , 121 ], and on EEG [ 122 ].…”

Section: Tens (Transcutaneous Electric Nerve Stimulation)mentioning

confidence: 99%

Central Sensitization-Based Classification for Temporomandibular Disorders: A Pathogenetic Hypothesis

Monaco

Cattaneo

Marci

et al. 2017

Pain Research and Management

View full text Add to dashboard Cite

Dysregulation of Autonomic Nervous System (ANS) and central pain pathways in temporomandibular disorders (TMD) is a growing evidence. Authors include some forms of TMD among central sensitization syndromes (CSS), a group of pathologies characterized by central morphofunctional alterations. Central Sensitization Inventory (CSI) is useful for clinical diagnosis. Clinical examination and CSI cannot identify the central site(s) affected in these diseases. Ultralow frequency transcutaneous electrical nerve stimulation (ULFTENS) is extensively used in TMD and in dental clinical practice, because of its effects on descending pain modulation pathways. The Diagnostic Criteria for TMD (DC/TMD) are the most accurate tool for diagnosis and classification of TMD. However, it includes CSI to investigate central aspects of TMD. Preliminary data on sensory ULFTENS show it is a reliable tool for the study of central and autonomic pathways in TMD. An alternative classification based on the presence of Central Sensitization and on individual response to sensory ULFTENS is proposed. TMD may be classified into 4 groups: (a) TMD with Central Sensitization ULFTENS Responders; (b) TMD with Central Sensitization ULFTENS Nonresponders; (c) TMD without Central Sensitization ULFTENS Responders; (d) TMD without Central Sensitization ULFTENS Nonresponders. This pathogenic classification of TMD may help to differentiate therapy and aetiology.

show abstract

Section: Tens (Transcutaneous Electric Nerve Stimulation)mentioning

confidence: 99%

Central Sensitization-Based Classification for Temporomandibular Disorders: A Pathogenetic Hypothesis

Monaco

Cattaneo

Marci

et al. 2017

Pain Research and Management

View full text Add to dashboard Cite

show abstract

“…On the contrary, transcutaneous electrical nerve stimulation (TENS) is believed to stimulate the hippocampus relevant to memory formation and the forebrain system degenerated in AD (38). TENS entails current applied transcutaneously to excite nerves, enhancing cognition in AD patients (38, 39).…”

Section: Non-invasive Brain Stimulationmentioning

confidence: 99%

“…TENS entails current applied transcutaneously to excite nerves, enhancing cognition in AD patients (38, 39). The hippocampus is stimulated by TENS via spinoseptal and brainstem nuclei such as the locus coeruleus (LC) and dorsal raphe nucleus (DRN) (38). The cholinergic basal forebrain system is reached by the LC and DRN via noradrenergic and serotonergic projections.…”

Section: Non-invasive Brain Stimulationmentioning

confidence: 99%

“…TENS can induce noradrenergic and serotonergic neuromodulation by this means. There is ongoing debate as to whether the effect of TENS is more prominent in mildly or severely affected AD patients (38, 39). TENS is effective in improving visual memory, long-term face recognition memory, and word fluency in AD patients (40).…”

Section: Non-invasive Brain Stimulationmentioning

confidence: 99%

See 1 more Smart Citation

Brain Stimulation for Combating Alzheimerâ€™s Disease

Hansen

2014

Front. Neurol.

View full text Add to dashboard Cite

“…Further therapeutic flops of the year were that Rofecoxib, a COX-2-inhibitor, did not delay the development of Alzheimer's disease [39] and transcutaneous electrical nerve stimulation did not improve memory [40].…”

Section: Treatmentmentioning

confidence: 99%